Advertisement

Topics

Bayer Combines Pharma R&D in one Unit

00:11 EST 13 Dec 2017 | CHEManager

From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas cardiology, gynecology, ophthalmology, hematology and oncology.

Original Article: Bayer Combines Pharma R&D in one Unit

NEXT ARTICLE

More From BioPortfolio on "Bayer Combines Pharma R&D in one Unit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...